CAR T cell therapy against CD19 and B cell maturation antigen (BCMA) is a potent immunotherapy for treating advanced B cell malignancies. It comes with a unique toxicity profile that includes cytokine ...

CAR T cells are genetically-altered cells that are designed to reset the immune system by targeting B cells, which are involved in the production of autoantibodies and lupus disease activity.

Memory T cells are a special type of white blood cell that "remember" past infections and vaccines, helping our bodies to ...

Please provide your email address to receive an email when new articles are posted on . A “complete eradication” of B cells with chimeric antigen receptor T-cell therapy is responsible for the ...

Studying T cells, the immune cells most responsible for responding to infections and cancers, just received a significant ...

Second solid malignancies after combined modality therapy for Hodgkin's disease. Sixty-nine patients were analyzed by immunochemistry. All patients were classified histologically, staged in a uniform ...

Please provide your email address to receive an email when new articles are posted on . It has been at least 2 years since the first cohort of patients with lupus underwent chimeric antigen receptor T ...

KOL panel to discuss how vispa-cel, an anti-CD19 allogeneic CAR-T cell therapy, can broaden access for patients with second-line large B cell ...